Home

We provide expert services in nanotechnology and drug particle engineering for the international pharma industry.

Our story

Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. Implementing CESS offers new technological and business advantages for the pharmaceutical industry.

Technology

Nanoform's Controlled Expansion of Supercritical Solutions - CESS - allows drug particle nanonization from 2000 nm down to less than 20 nm. This bottom-up method is based on recrystallization, by controlling solubility of the API in supercritical carbon dioxide.

Expert Services

The proprietary CESS technology offers new technological and business advantages for the pharmaceutical industry. With our technology your company can increase the bioavailability of drug molecules and develop new, more efficient drugs. Improve the bioavailability of your API: try nanonization for drug development, reformulation and industrial production.

Service

The proprietary CESS technology offers new technological and business advantages for the pharmaceutical industry. With our technology your company can increase the bioavailability of drug molecules to develop new, more efficient drugs.

Team

Nanoform was founded by a group of highly experienced professionals with a strong track record in pharmaceutical and healthcare industries, as well as in the management of successful collaborative projects between academy and industry. The other members of the team are experts in i.a. engineering, physics, drug development and clinical trials.